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Background: In the heart, cytoplasmic actin networks are thought to have important roles in mechanical support,
myofibrillogenesis, and ion channel function. However, subcellular localization of cytoplasmic actin isoforms and
proteins involved in the modulation of the cytoplasmic actin networks are elusive. Mena and VASP are important
regulators of actin dynamics. Due to the lethal phenotype of mice with combined deficiency in Mena and VASP,
however, distinct cardiac roles of the proteins remain speculative. In the present study, we analyzed the
physiological functions of Mena and VASP in the heart and also investigated the role of the proteins in the
organization of cytoplasmic actin networks.
Results: We generated a mouse model, which simultaneously lacks Mena and VASP in the heart. Mena/VASP
double-deficiency induced dilated cardiomyopathy and conduction abnormalities. In wild-type mice, Mena and
VASP specifically interacted with a distinct αII-Spectrin splice variant (SH3i), which is in cardiomyocytes exclusively
localized at Z- and intercalated discs. At Z- and intercalated discs, Mena and β-actin localized to the edges of the
sarcomeres, where the thin filaments are anchored. In Mena/VASP double-deficient mice, β-actin networks were
disrupted and the integrity of Z- and intercalated discs was markedly impaired.
Conclusions: Together, our data suggest that Mena, VASP, and αII-Spectrin assemble cardiac multi-protein
complexes, which regulate cytoplasmic actin networks. Conversely, Mena/VASP deficiency results in disrupted
β-actin assembly, Z- and intercalated disc malformation, and induces dilated cardiomyopathy and conduction
abnormalities.
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Actin dynamics regulate a tremendous range of cellular
functions. Currently, it is believed that different actin
isoforms and their associated actin-binding proteins
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reproduction in any medium, provided the orcytoplasmic actin networks are thought to have import-
ant roles in mechanical support, myofibrillogenesis, and
ion channel function [2] and elevated levels of cytoplas-
mic actin have been reported in dilated cardiomyopathy
(DCM) [3]. Indeed, the α-cardiac actin isoform is the
major constituent of thin filaments in the sarcomeres,
but circumstantial evidence supports the existence of a
different actin isoform at Z- and intercalated discs, pos-
sibly β- or γ-cytoplasmic actin [2,4,5].
Proteins of the Enabled/vasodilator-stimulated phos-
phoprotein (Ena/VASP) family are important mediatorsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ing pathways to actin assembly [6]. In the mammalian
heart, two Ena/VASP proteins are predominantly ex-
pressed, mammalian Enabled (Mena) and VASP [7].
Mena and VASP increase actin filament assembly by
their intrinsic polymerase and anti-capping activities [8]
and the latter are impaired by the cyclic nucleotide-
dependent phosphorylation of the proteins [9-11]. Be-
cause of their ability to modulate distinct modes of actin
organization, it has been proposed that Mena and VASP
may serve as higher order regulators of the actin cyto-
skeleton [12]. Given their essential role in regulating
actin dynamics, it was surprising that the deletion of the
genes encoding Mena or VASP in mice resulted in only
mild neuronal or platelet dysfunction [13-16]. One ex-
planation for the lack of a pronounced phenotype could
be the mutual functional compensation of the proteins.
Consistent with this hypothesis, functional abnormalities
in Mena−/− or VASP−/− mice were detected in tissues
that predominantly express only one of the family mem-
bers [7] and human VASP has been shown to rescue the
lethal phenotype in Drosophila Ena−/− mutants [17].
Furthermore, Mena/VASP double-deficient mice die
perinatally and suffer from severe defects in brain mor-
phology [18]. However, a single allele of Mena is suffi-
cient to rescue the embryonic lethal phenotype [13].
In cardiac muscle cells, scaffold proteins of the Spectrin
family coordinate macromolecular protein complexes,
which organize transmembrane signaling proteins and
at the same time enable muscle cells to resist the ex-
treme forces of contraction [19-21]. αII-Spectrin is
abundant at the lateral plasma membrane but it is also
enriched at Z- and intercalated discs close to the edges
of the sarcomeres [22]. At the intercalated discs, αII-
Spectrin is a critical component of the transitional
junction, an axial interface located where the thin actin
filaments of the terminal sarcomere continue into the
adherens junctions [4]. The critical role of αII-Spectrin
in maintaining cardiac integrity is demonstrated by the
fact that αII-Spectrin-deficient embryos die in utero
and exhibit abnormal cardiac shape, cardiac dilation,
and thinning of the myocardium [23]. These cardiac
deformities are the likely cause of the embryonic lethal-
ity and reminiscent of the cardiac phenotypes induced
by the loss of proteins that regulate actin dynamics
[23]. Given that the direct interaction of VASP and αII-
Spectrin initiates β-actin filament assembly and stabi-
lizes cell-cell contacts [10], it is tempting to speculate
that αII-Spectrin:Mena/VASP complexes may be im-
portant for the formation and stability of cytoplasmic
actin networks in the heart.
In the present study, we aimed to address cardiac
functions of Mena and VASP using a combination of
mouse models lacking either Mena or VASP, or bothproteins in the heart. Mechanistically, we focused on the
role of Mena/VASP in the organization of cytoplasmic
actin networks and whether this has implications for
mechanical support, myofibrillogenesis, and ion channel
function in the mammalian heart.
Results
Stage-dependent expression of cytoskeletal proteins in
the mouse heart
To determine the cardiac functions of Mena and VASP
and the associated cytoskeletal proteins, αII-Spectrin
and actin, we analyzed the protein levels in wild-type
mouse hearts by Western blotting. For this, we gener-
ated a polyclonal anti-Mena antibody using a fusion pro-
tein that comprises the LERER region of mouse Mena
for immunization and the specificity of the purified anti-
bodies was controlled by Western blotting. Consistent
with the reported apparent molecular weight of mouse
Mena in Western blots [7], our antibody detected a pro-
tein band at ~80 kDa, which was only seen in lysates of
Mena-transfected, but not in the MOCK-transfected
cells (Figure 1A, upper panel, lanes 1 and 2). We also in-
vestigated lysates of CHO-S cells with a stable integra-
tion of GST-Mena [24]. Our Mena-specific antibody
(Figure 1A, upper panel, lanes 3 and 4) as well as a
GST-tag-specific antibody (middle panel, lanes 3 and 4)
displayed a signal at ~110 kDa, which was only visible in
lysates of GST-Mena expressing cells but not in controls.
Consistent with the absence of LERER repeats in VASP
[6], our Mena antibody did not detect the purified VASP
protein in Western blots (Figure 1B).
In the mouse heart, at least two Mena isoforms exist.
The ubiquitously expressed isoform, which migrates
with an apparent molecular weight of ~80 kDa and a
splice variant, which is predominantly expressed in neur-
onal tissue and migrates at about 140 kDa (Figure 1C).
VASP migrates with an apparent molecular weight of 46
kDa in SDS-PAGE, but PKA-mediated phosphorylation
of VASP on Ser157 induces an electrophoretic mobility
shift of the protein from 46 to 50 kDa (Figures 1C and
D). Thus, depending on PKA activity in the heart, one
or two protein bands can be observed in Western blots.
We investigated protein expression in hearts of 1-week-old
and adult mice under basal conditions, as well as the hearts
of adult mice subjected to transverse aortic constriction
(TAC) for 3 weeks to induce left-ventricular hyper-
trophy. The expression patterns of the investigated pro-
teins showed a comparable trend. αII-Spectrin, Mena,
VASP, and β-cytoplasmic actin were highly expressed in
1-week old hearts and protein levels declined until
adulthood (Figures 1C and D). Consistent with the
reactivation of the fetal gene expression program, pro-
tein levels were significantly increased in hypertrophic
hearts (Figure 1C). Taken together, the expression of
Figure 1 Stage-dependent expression of cytoskeletal proteins in the mouse heart. (A, B) Characterization of Mena-specific antibodies. (A)
CHO-S cells, either transiently transfected with murine Mena (CMV-Mena) or stably transfected with GST-tagged Mena (GST-Mena), were lysed and
analyzed by Western blotting with Mena-specific (upper panel) or GST-specific (middle panel) antibodies. As control, lysates of MOCK-transfected
cells or lysates of CHO-S cells without stable integration of GST-Mena were run on the same gels. β-Tubulin served as loading control (lower
panel). (B) 100 ng purified VASP protein was probed by Western blotting with anti-VASP (left panel) and anti-Mena (right panel) antibodies. (C, D)
Stage-dependent expression of cytoskeletal proteins in the mouse heart. (C) Lysates of 1-week-old, adult, and hypertrophic adult mouse hearts
were probed by Western blotting with antibodies against αII-Spectrin, Mena, VASP, and β-cytoplasmic actin. Blotting for β-Tubulin was used as
invariant loading control. Two Mena isoforms are expressed in the mouse heart, the general (~80 kDa) and the neuronal-specific (~140 kDa) form.
Depending on its phosphorylation state, VASP migrates at 46 or 50 kDa. (D) VASP expression in the mouse heart at postnatal day 1, 10, and 20
and in the adult heart.
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cytoplasmic actin and αII-Spectrin in the 1-week old,
adult, and hypertrophied mouse heart.
Targeted disruption of mouse Mena
The mouse Mena gene is composed of 17 exons lo-
cated on chromosome 1 (Figure 2A) and a neuronal-
specific and a ubiquitous Mena protein isoform are
generated by differential splicing. Both isoforms share
the N-terminal Ena/VASP homology 1 (EVH1) do-
main, the LERER repeats, the proline-rich region
(PRR), and the C-terminal EVH2 domain (Figure 2B
and [25]). To target Mena gene expression, we used
the murine embryonic stem (ES) cell line RRG138, in
which one Mena allele has been disrupted by insertion
of a gene trap vector in intron 2 (Figure 2A, black
arrow and 2C). Upon transcription/translation of the
“trapped” Mena gene, the endogenous full-length pro-
tein is replaced by a fusion-protein encoded by the
first two Mena exons and the reporter gene. Because
Mena exon 3 encodes critical parts of the N-terminal
EVH1 domain, a key feature of all known Mena
protein isoforms, the resulting Mena/β-geo fusion pro-
tein most likely lacks all endogenous Mena functions
(Figure 2C). Following blastocyst injection of the ES
cells, mice that were homozygous for the gene-trap in-
sertion (MenaGT/GT) were generated. MenaGT/GT mice
were viable, fertile, and macroscopically indistinguish-
able from wild-type controls.Generation of Mena/VASP double-deficient mice
(MenaGT/GTVASP−/−, dKO)
When we analyzed Mena protein levels in our MenaGT/GT
mice, we found that specifically in the brain, but not
in other organs, the gene trap was “leaky” [27,28],
resulting in a low amount of endogenous full length
protein (data not shown but compare Mena protein
levels in the MenaGT/GTVASP−/− organs, Figure 3A,
dKO lanes). We speculated that the residual Mena
expression in the brain of MenaGT/GT mice may over-
come the embryonic lethal phenotype of Mena/VASP
double-deficient mice and crossed the MenaGT/GT ani-
mals with our VASP−/− mice [16]. Indeed, the re-
maining Mena protein expression in the brain was
sufficient to produce viable mice (MenaGT/GTVASP−/−).
In agreement with our previous studies [7], the general
Mena isoform (80 kDa) was detected in protein extracts
from wild-type heart, lung, brain, and spleen. In wild-
type heart and brain the antibodies also detected the
neuronal splice variant (140 kDa; Figure 3A, WT lanes).
In lysates from MenaGT/GTVASP−/− mice, Mena ex-
pression was nearly undetectable in heart, lung, and
spleen (Figure 3A, dKO lanes). In contrast, in brain
protein extracts from MenaGT/GTVASP−/− mice, both
Mena isoforms were only moderately decreased (by ap-
proximately 70%) versus protein levels in wild-type
mice (Figure 3A). We could not detect VASP protein
expression in any organ from MenaGT/GTVASP−/− mice
(Figure 3B).
Figure 3 Mena/VASP expression in wild-type and MenaGT/GTVASP−/− mouse organs. Western blots to analyze Mena (A) and VASP (B)
protein levels in heart, lung, brain, and spleen of wild-type (WT) and MenaGT/GTVASP−/− (dKO) mice. GAPDH and lysates of Mena- or VASP-transfected
cells were used as controls. (A) The general Mena protein isoform (~80 kDa) is present in all analyzed organs, the neuronal splice variant (~140 kDa) is
only detected in heart and brain. Whereas Mena protein in dKO brain is moderately reduced to ~30% of wild-type levels, Mena is almost undetectable
in heart, lung, and spleen. The 130 kDa band seen in heart, lung, and brain likely represents a cross-reaction with an unrelated protein. (B) VASP (46 or
50 kDa, depending on phosphorylation state) expression is high in the neonatal heart and the adult lung and spleen, low in the adult heart, and nearly
undetectable in the brain. No VASP protein is detected in dKO organs.
Figure 2 Targeted disruption of the mouse Mena gene. (A) The mouse Mena gene is located on chromosome 1 spanning about 115 kb of
genomic sequence. The translational start and termination codons are given in green (exon 1) and red (exon 16), respectively. The neuronal-specific
exons are shown in green. Exons 2 and 3, encoding the Ena/VASP homology 1 (EVH1) domain are shown in red. Exons encoding the LERER repeats,
the proline-rich region (PRR), and the EVH2 domain are indicated in orange, grey, and light blue, respectively. The insertion of a gene trap
vector in intron 2 of the Mena gene is indicated by a black arrow (compare C). (B) Depending on differential splicing, a
neuronal-specific and a general Mena protein isoform exist. Mena is phosphorylated at serine 236 by PKA (green “S”) and at serine 376 by PKG
(yellow “S”; numbering according to the 541aa general Mena isoform). (C) In the ES cell clone RRG138, the gene trap vector is inserted in Mena
intron 2. The gene trap vector consists of a splice acceptor side (SA), a polyadenylation signal (pA), and β-geo, which encodes β-galactosidase
and neomycin resistance [26]. Insertion of the gene trap vector disrupts the Mena gene and results in the expression of a Mena/β-geo fusion
protein. Because critical parts of the N-terminal EVH1 domain are missing in the fusion protein, Mena/β-geo most likely lacks all known
endogenous Mena functions.
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and hypertrophy
We first investigated heart weight to tibia length (HW/
TL) ratios in adult VASP-deficient (V-KO), MenaGT/GT
(M-KO), and MenaGT/GTVASP−/− (dKO) animals. The
HW/TL ratio of VASP-deficient mice was undistinguish-
able from wild-type controls and although the ratio of
the MenaGT/GT mice was slightly elevated, this trend did
also not reach significance. In contrast to the individual
knockouts, the HW/TL ratio of the MenaGT/GTVASP−/−
animals was significantly increased by over 20% com-
pared to wild-type controls (Figure 4A and B).
Histological analyses of MenaGT/GTVASP−/− hearts re-
vealed substantial dilation of both ventricles compared to
wild-type hearts (Figure 4C and D), indicating eccentric
hypertrophy. Dilated ventricles were not observed in the
MenaGT/GT or VASP−/− mice (compare end-diastolic areas
in echocardiography, Figure 5C). In the MenaGT/GTVASP−/−
mice, cardiac dilation was also associated with marked inter-
stitial fibrosis (Figure 4E and F).
Consistent with cardiac fibrosis and hypertrophy, cross
sectional areas of cardiomyocytes were significantly ele-
vated in the MenaGT/GTVASP−/− animals (Figure 4G) as
were mRNA levels of the cardiac hypertrophy markers;
β-myosin heavy chain and atrial natriuretic peptide, and
the fibrosis markers; α-smooth muscle actin, collagen I
and collagen III (Figure 4H).
Mena/VASP double-deficiency induces DCM and
conduction abnormalities
Decompensated eccentric hypertrophy and cardiac dila-
tion are characterized by a reduced functional perform-
ance of the heart [29]. Therefore, we investigated left
ventricular function by echocardiography under basal
conditions. M-mode and two-dimensional recordings at
the mid-papillary muscle level revealed clear differences
between wild-type and mutant mice. The left ventricles
of MenaGT/GT, VASP−/− and MenaGT/GTVASP−/− animals
displayed significantly increased end-systolic areas com-
pared to wild-type controls (Figure 5A and B). However,
the MenaGT/GT and MenaGT/GTVASP−/− animals were
more affected than the VASP−/− mice. A significant in-
crease in the end-diastolic area was only observed in the
MenaGT/GTVASP−/− mice (Figure 5A and C) and is in
agreement with the histological data (see Figure 4).
Consistent with an impaired cardiac contraction,
MenaGT/GTVASP−/− mice displayed a significantly re-
duced fractional shortening compared to wild-type ani-
mals (WT 61.4% vs. dKO 53.0%, *P<0.05, n=13). To
directly assess hemodynamic parameters in wild-type
and mutant animals, we analyzed left ventricular pres-
sures by invasive catheterization. Consistent with the oc-
currence of dilated ventricles, the end-systolic pressure
was significantly reduced in the MenaGT/GTVASP−/− butnot in the wild-type, MenaGT/GT, or VASP−/− animals
(Figure 5D). Rates of left ventricular pressure increase
were not significantly different between the groups (data
not shown). Consistent with the pronounced interstitial fi-
brosis, however, the rate of left ventricular pressure decline
was diminished in MenaGT/GTVASP−/− mice (Figure 5E).
Next, we investigated the impact of Mena/VASP defi-
ciency on the electrical conduction in the mammalian
heart and performed high resolution ECG recordings
(Figure 6). Although heart rates were nearly identical in
all strains (wild-type 441 bpm, VASP−/− 434, MenaGT/GT
432 bpm, MenaGT/GTVASP−/− 439 bpm), PQ and QRS
intervals, which reflect the intra-atrial and the intra-
ventricular propagation of electrical signals, respectively,
were significantly prolonged in the MenaGT/GT, VASP−/−,
and MenaGT/GTVASP−/− mice. Interestingly, the differ-
ences in the MenaGT/GTVASP−/− animals were statisti-
cally indistinguishable from those observed in the
MenaGT/GT and VASP−/− mice (Figure 6).
Mena is localized at Z- and intercalated discs of mouse
cardiomyocytes
Circumstantial evidence suggests that cytoplasmic ac-
tin networks are present at Z- and intercalated discs of
cardiomyocytes with implications for mechanical sup-
port, myofibrillogenesis and ion channel function
[1,2,4,5]. To determine whether or not the regulation
of cytoplasmic actin dynamics at Z- and intercalated
discs may be exerted through Mena and VASP, we in-
vestigated the sub-cellular distribution of the proteins
by confocal microscopy and initially focused on Mena,
which is more robustly expressed in the adult heart. In
adult wild-type hearts, a fraction of Mena was local-
ized at Z-discs, where it colocalized with CapZ, a pro-
tein that acts as a barbed end capping protein for F-
actin and that is found at the end of the thin filaments
in the Z-disc (Figure 7A). The majority of Mena, how-
ever, was detected at intercalated discs, where it at
least partially colocalized with Connexin 43, a critical
component of the gap junctions, which carry the elec-
trical stimulus from cell to cell (Cx43, Figure 7B). To
exclude channel crosstalk and sectioning artifacts, we
also analyzed the subcellular distribution of Mena in
isolated murine cardiac myocytes. Consistent with the
findings from the intact heart, Mena was localized to
Z-discs of isolated cardiomyocytes as well as to cell
termini, which correspond to the intercalated discs in
heart tissue (Figure 7C).
Conventional confocal microscopy has a limited axial
resolution of >200 nm. Thus it is difficult to distinguish
whether the proteins detected are truly Z-disc proteins
or simply associated with nearby structures, i.e. T-
tubules. To more accurately determine the subcellular
distribution of Mena, we subjected ultrathin sections of
Figure 4 Enlarged and dilated hearts in MenaGT/GTVASP−/− mice. MenaGT/GTVASP−/− (dKO) animals display macroscopically enlarged hearts (A,
photography, scale in cm) and significantly increased heart weight to tibia length ratios as compared to wild-type (WT) controls (B; ANOVA,
*P<0.05). (C, D) Hematoxilin and eosin stained cross sections of MenaGT/GTVASP−/− (C) and wild-type (D) hearts, demonstrating dilated ventricles
in the double-deficient animals. (E, F) Picrosirius red stained heart cross sections of dKO (E) and WT (F) mice to visualize collagen fibers/interstitial
fibrosis. Magnified views of the indicated areas are shown as insets. The scales in images C-F are given in mm. (G) Cross sectional areas of
cardiomyocytes from WT and MenaGT/GTVASP−/− hearts quantified by morphometric analyses (five animals per group, 25 cardiomyocytes per
animal, *P<0.05). (H) Quantitative real-time RT-PCR revealed increased mRNA levels of cardiac hypertrophy markers (β-myosin heavy chain,
β-MHC; atrial natriuretic peptide, ANP) and fibrosis markers (α-smooth muscle actin, α-SMA; collagen I, Col I; and collagen III, Col III; *P<0.05; n=6)
in dKO mice vs. WT controls.
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Consistent with the results of the confocal microscopy
studies, a fraction of Mena immunoreactivity was detectedat Z-discs and the gold particles especially localized to-
wards the edges of the adjacent sarcomeres (Figure 8A).
The strongest Mena immunogold signal, however, was
Figure 5 Mena/VASP double-deficiency induces dilated cardiomyopathy. (A-C) Echocardiography. (A) Representative M-mode recordings at
the mid-papillary muscle level of wild-type (WT) and MenaGT/GTVASP−/− (dKO) mice. (B, C) Statistical analyses of the echocardiographic
measurements demonstrated a significantly increased left intraventricular end-systolic area in VASP−/− (V-KO), MenaGT/GT
(M-KO), and MenaGT/GTVASP−/− (dKO) animals as compared to wild-type controls (B). The left intraventricular end-diastolic area was only
significantly increased in the dKO animals (C). (D, E) Left ventricular catheterization revealed a significantly reduced end-systolic pressure (D) and
a significantly reduced rate of pressure decline (E) in the left ventricle of dKO mice. Bars represent the mean ± S.E.M (ANOVA, *P<0.05).
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membrane itself was not labeled. Indeed the majority
of gold particles accumulated within the cytoplasmic
edge of the dark plaque material that coats the mem-
branes where the thin filaments of the terminal sarco-
meres lead into the adherens junctions (Figure 8B). We
also investigated the subcellular distribution of cyto-
plasmic actin isoforms. Similar to Mena, β-cytoplasmic
actin was also detected at Z- and intercalated discs. At
Z-discs, however, β-actin labeling was not limited
to the edges of sarcomeres, but instead was almost
evenly distributed, indicating that β-actin is an integral
component of the Z-discs. At intercalated discs, again
most gold particles localized to the edges of the adja-
cent sarcomeres and closely matched the sub-cellulardistribution of Mena (Figure 8C and D). In contrast to
Mena and β-actin, γ-actin was neither detectable at the
Z-discs nor within the I-bands of the sarcomeres. In-
stead, most gold particles were observed at the mito-
chondria in the vicinity of I-Z-I bands in cardiac
myofibrils. High power magnifications suggested that
γ-actin is an integral part of the filamentous structures,
which project from the upper and lower terminals
of Z-discs towards the mitochondria (Figure 8E). Weak
immunoreactivity with small gold particle clusters
was also detected inside the intercalated discs, likely
representing γ-actin association with local micro-
compartments. In contrast to Mena and β-actin, how-
ever, no γ-actin labeling was detected at the edges of
the terminal sarcomeres (Figure 8F).
Figure 6 Mena/VASP double-deficiency results in conduction abnormalities. Electrocardiography (ECG). (A) Original, high resolution lead I
ECG recording of a representative MenaGT/GTVASP−/− (dKO, upper panel) and wild-type (WT, lower panel) mouse. Q, R, and S spikes and the
P- and T-waves are indicated. A comparison of the PQ and QRS intervals from dKO and WT mice is shown below the ECG recording of the WT.
(B, C) Statistical analysis of the ECG recordings demonstrated significantly prolonged PQ (B) and QRS (C) intervals in VASP−/− (V-KO), MenaGT/GT
(M-KO), and MenaGT/GTVASP−/− (dKO) mice. Bars represent the mean ± S.E.M, one-way analysis of variance (ANOVA), *P<0.05).
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Spectrin splice variant
αII-Spectrin-deficient mice die from severe cardiac abnor-
malities that are reminiscent of phenotypes observed fol-
lowing the loss of proteins that regulate actin dynamics,
such as Mena and VASP [23]. Thus, the cardiac pheno-
type observed in αII-Spectrin-deficient mice may, at least
in part, be related to the failure to complex with Mena
and VASP at Z- and intercalated discs. To test this hy-
pothesis, we compared the sub-cellular distribution of
Mena with that of αII-Spectrin and the αII-Spectrin splice
variant; SH3i, which contains a 20-amino acid insertion
C-terminal to the SH3 domain and is also present in the
mouse heart [30]. αII-Spectrin was found enriched at the
lateral plasma membrane as well as at Z- and intercalated
discs, where it colocalized with Mena and F-actin
(Figure 9A). More detailed analyses of protein distribution
revealed a doublet appearance of Mena and αII-Spectrin
across the intercalated disc (Figure 9A) and is consistent
with co-localization of the proteins at the transitional
junction, a sharp boundary that lies between the last
sarcomere and the intercalated disc thin filaments [4,22].
In contrast, the SH3i splice variant was exclusively found
at Z- and intercalated discs and not at the lateral plasma
membrane. Therefore, SH3i closely paralleled the subcel-
lular distribution of Mena and indeed the proteinsdisplayed a high degree of colocalization at Z- and interca-
lated discs (Figure 9B), indicating that SH3i may be im-
portant for Mena targeting or function in the heart.
Consistently, quantitative immunocolocalization analysis
[31] revealed significantly higher Pearson’s correlation and
Mander’s overlap coefficients of Mena versus SH3i than
Mena versus total αII-Spectrin (Pearson’s 0.73 versus 0.65;
Mander’s 0.94 versus 0.85, n=24, *P<0.05). Importantly,
colocalization of Mena and SH3i with F-actin was limited
to Z- and intercalated discs and no colocalization with
sarcomeric F-actin was observed, indicating that the asso-
ciation of Mena and SH3i with the α-cardiac actin fibers
of the contractile machinery is minor (Figure 9B).
Next, we compared binding of Mena/VASP to general
αII-Spectrin and the SH3i isoform. The difference be-
tween αII-Spectrin and the SH3i isoform is a 20 amino
acid insertion C-terminal to the SH3 domain in the SH3i
(Figure 10A). To determine whether or not this insertion
could alter αII-Spectrin binding to Mena and VASP, we
generated, expressed, and purified a series of GST-fusion
proteins (Figure 10B and C). In addition to GST alone,
which served as negative control, these GST-fusion pro-
teins included the alternatively spliced 20 amino acids (A),
the SH3 domain (SH3), the α9 repeat of αII-Spectrin (α9),
and the α9 repeat of SH3i, which includes the alternatively
spliced 20-amino acids (α9A). In GST pull-down
Figure 7 Mena is localized at Z- and intercalated discs of mouse cardiomyocytes. (A, B) Confocal microscopy images of adult mouse heart
cryosections stained for Mena (a, green), non-isoform selective F-actin (b,red), and CapZ (A, image c, blue) or Connexin 43 (Cx43, B, image c,
blue). Mena and F-actin colocalized with CapZ at Z-dics (A, merged images d-f, arrowheads) and with Cx43 at intercalated discs (B, merged
images d-f, arrows). (C) Adult mouse cardiomyocytes were single-stained with Mena-specific antibodies followed by fluorescence-conjugated
secondary antibodies (images a and b). Image b shows a magnified view of the area indicated in image a. Mena localized to Z-discs
(arrowheads) and was strongly enriched at the cell termini (arrows). Using identical laser intensities and capture settings, the fluorescent
secondary antibodies alone did not reveal any cross-striated signals (image c, negative control). Scale bars 15 μm.
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least 10-fold more Mena than α9 or SH3 (Figure 10D). In-
terestingly, the 20 amino acid insert alone was not suf-
ficient for Mena binding. To analyze VASP binding
in the same assay, we performed GST pull-downs with
neonatal mouse heart lysates. Similar to Mena, interaction
of VASP with α9A was more prominent than the inter-
action with α9 or SH3 (Figure 10E).The interaction between Mena/VASP and SH3i, requires a
functional SH3 domain and is regulated by
phosphorylation
To characterize the formation of the Mena/VASP:α9A
complex in more detail we determined whether a func-
tional SH3 domain was essential for binding or whether
α9A forms an SH3-independent site for Ena/VASP
docking. The binding of SH3 domains to proline-rich
Figure 8 Mena and β-actin localize to the edges of sarcomeres at Z- and intercalated discs. Immuno-electron microscopy of Z- and
intercalated disc regions in mouse papillary muscle. Sections were labelled with antibodies to Mena (A, B), β-actin (C, D), and γ-actin (E, F).
The dashed line in the insets of B and D indicates the cytoplasmic edge of the dark plaque material that coats the plasma membranes where the
thin filaments of the terminal sarcomeres lead into the adherens junctions. (E) Most γ-Actin immunogold labeling was observed at filamentous
structures, which project from the upper and lower terminals of Z-discs towards the mitochondria. Scale bars 500 nm.
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within the SH3 domain. To abrogate the binding of the
SH3 domain, we substituted a highly conserved tryptophan
residue (W1004) which is critically involved in formation
of the second hydrophobic binding pocket [32], with an ar-
ginine residue to generate the W1004R point mutant. In
GST pull-down experiments with mouse heart lysates,
Mena binding to W1004R was markedly reduced versus
binding to α9A and was comparable to the background
binding to GST alone (Figure 10F). We have previously
shown that the PKA-mediated phosphorylation of VASPimpairs its interaction with the SH3 domain of αII-
Spectrin [10]. Because the interaction of Mena and VASP
with α9A appeared to be stronger than the interaction
with either α9 or SH3 (Figure 10D and E), we investigated
whether the binding of α9A to VASP is also regulated by
PKA. Therefore, purified recombinant VASP was phos-
phorylated with activated PKA in vitro, which resulted in
the complete phosphorylation of the protein on Ser157
(Figure 10G). In subsequent pull-down assays, α9A readily
precipitated the non-phosphorylated, but not the PKA-
phosphorylated protein (Figure 10G).
Figure 9 Mena specifically colocalizes with the αII-Spectrin splice variant SH3i. (A, B) Confocal microscopy images of adult mouse heart
cryosections stained for Mena (a, green), F-actin (b, red), and total αII-Spectrin (A, image c, blue) or the αII-Spectrin splice variant SH3i (B, image c, blue).
(A) Mena, F-actin, and a portion of total αII-Spectrin colocalized at Z-discs (A, merged images d-f, arrowheads) and intercalated discs (A, merged
images d-f, arrows. Detailed analyses revealed a doublet appearance of the proteins across the intercalated disc (A, images d-f, insets). Most αII-
Spectrin was detected at the lateral plasma membrane (A, image c, asterisks) and colocalization with Mena and F-actin at these sites was minor. (B)
SH3i was exclusively detected at Z- and intercalated discs but was absent from the lateral plasma membrane compare image c of A and B). Merged
images d-f and magnified views of the indicated areas therein (images g-i) revealed high degree of colocalization of Mena and SH3i at Z-discs (images
g-i, arrowheads) and intercalated discs (arrows), the lateral boundaries of the sarcomeres, which are exemplarily highlighted by brackets. Outside Z-
and intercalated discs, colocalization of Mena and SH3i with F-actin was minor. Scale bars in images c and f 15 μm, image i 5 μm.
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Spectrin splice variant SH3i is the prominent Mena/
VASP interaction partner at Z- and intercalated discs.
Moreover, the SH3 domain of SH3i is essential for com-
plex formation and PKA-mediated VASP phosphoryl-
ation impairs its binding in vitro.Mena and SH3i establish multi-protein complexes at
Z- and intercalated discs
To determine whether SH3i and Mena form complexes
in vivo and to elucidate whether or not the proteins are im-
portant structural components of Z- and intercalated discs,
we performed immunoprecipitation (IP) studies from
Figure 10 C-terminal extension of the αII-Spectrin SH3 domain enhances interaction with Mena and VASP. (A) αII-Spectrin is composed
of 21 triple-helical repeats. Two αII-Spectrin splice variants exist in the mouse heart, either with or without a 20-amino acids insertion in the 9th
repeat (“A”), C-terminal to the SH3 domain (indicated in red). The splice variant with the insertion is termed SH3i. (B, C) Schematic diagram (B)
and Coomassie stained gel (C) of the purified GST-αII-Spectrin fusion proteins used for the pull-down experiments shown in D-G. Two microgram
bovine serum albumin (BSA) served to calibrate the protein load. (D, E) Lysates of adult (D) and neonatal (E) mouse hearts were incubated with
the depicted GST-fusion proteins and the precipitated material was blotted with Mena- or VASP-specific antibodies, respectively. (F) The
interaction between Mena and SH3i, requires a functional SH3 domain and mutation of α9A to exchange the conserved Trp1004 residue with an
arginine (W1004R) abrogates the binding. (G) The interaction between purified recombinant VASP and SH3i is regulated by phosphorylation.
GST-α9A readily precipitated the non-phosphorylated VASP (46 kDa), but not PKA-phosphorylated protein (pS157-VASP, 50 kDa).
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precipitated total αII-Spectrin and SH3i but the ratio of
precipitate to input (heart lysate) was greater for SH3i than
αII-Spectrin (Figure 11A). Moreover, given that the anti-
body against αII-Spectrin also detects the SH3i splice vari-
ant (but not vice versa) it seemed that the preferred
interaction is between Mena and the SH3i splice variant.
Consistently, SH3i-specific antibodies precipitated 8-fold
more Mena protein than general αII-Spectrin-specific anti-
bodies (Figure 11B-D). Mena was also found to complex
with actin, sarcomeric α-actinin, and Cx43 (Figure 11A).
We also investigated the interaction of αII-Spectrin or SH3i
with Cx43 and found that, similar to its binding to Mena,SH3i precipitated significantly more Cx43 (6.6-fold) than
αII-Spectrin (Figure 11 B-D). In contrast, complex forma-
tion of αII-Spectrin or SH3i with actin and sarcomeric α-
actinin was similar. Ena/VASP proteins associate at or near
the barbed ends of actin filaments thereby restricting the
access of barbed end capping proteins. In our IP studies,
we investigated the association of Mena, αII-Spectrin, and
SH3i with CapZ, an F-actin capping protein at Z-discs. Al-
though Mena, αII-Spectrin, and SH3i are also found at Z-
discs in cardiac myocytes, we could not detect a physical
association between any of the actin binding proteins and
CapZ (Figure 11), indicating a mutually exclusive binding
of the proteins to actin.
Figure 11 Mena and SH3i establish multi-protein complexes at Z- and intercalated discs. Representative Western blots of
Immunoprecipiation (IP) studies. Lysates of adult mouse hearts were immunoprecipitated with Mena-specific (A), general αII-Spectrin-specific (B),
or SH3i-specific (C) antibodies and the precipitated material was probed with antibodies against total αII-Spectrin, SH3i, Mena, actin, the Z-disc
components α-Actinin and CapZ, and the intercalated disc marker Connexin 43 (Cx43). Western blot analysis of the precipitated material with the
same antibodies that were used for IP served as control (lowermost panel in A, B, and C). Mena, αII-Spectrin, and SH3i were found in complexes
with actin, α-Actinin and Cx43, but not in complexes with CapZ. (D) Statistical analysis of Mena and Cx43 protein amounts in IPs with general
αII-Spectrin-specific (black bars) or SH3i-specific antibodies (white bars). SH3i precipitated more Mena and Cx43 than αII-Spectrin. Bars represent
the mean ± S.E.M (ANOVA, *P<0.05).
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disc integrity
Our data revealed that αII-Spectrin/SH3i, Mena, and actin
form multi-protein complexes in cardiomyocytes. To test
if these complexes are important for the structural integ-
rity of Z- and intercalated discs, we compared the mor-
phology of hearts from wild-type and MenaGT/GTVASP−/−
mice by pre-embedding immunogold electron micro-
scopy. First, we focussed on the morphology of the Z-discs
and labeled thin sections with anti α-Actinin anti-
bodies. In sections from wild-type and MenaGT/GTVASP−/−
mice, immunogold particles were equally found at Z-
discs. However, compared to the wild-type sections,
the integrity of the Z-discs in the MenaGT/GTVASP−/−
mice was markedly altered and demonstrated a wavy and
fractured appearance (Figure 12A and B). The thinfilaments of the contractile apparatus are anchored at Z-
discs and consistent with the ruptured Z-discs in the
MenaGT/GTVASP−/− hearts, the morphology of actin fila-
ments in the I-band also appeared disorganized and cha-
otic (Figure 12A and B). Next, we assessed whether
Mena/VASP deficiency affects the localization of αII-
Spectrin/SH3i at Z-discs. In contrast to sections from
wild-type hearts where the proteins were almost equally
spread along the Z-disc, clusters of αII-Spectrin and SH3i
were found within the ruptured Z-discs and often associ-
ated with the emerging gaps in cardiac Z-discs from
MenaGT/GTVASP−/− mice (Figure 12C-F). Gamma-actin la-
beling at the filamentous structures projecting from the Z-
disc termini to the mitochondria was indistinguishable in
wild-type and MenaGT/GTVASP−/− heart sections (data not
shown) but the β-actin pattern was markedly altered in
Figure 12 Mena/VASP double deficiency impairs Z- and intercalated disc integrity. Immuno-electron microscopy of Z- and intercalated disc
regions in wild-type and MenaGT/GTVASP−/− mouse papillary muscle. Sections were labelled with antibodies to α-Actinin (A, B), αII-Spectrin (C, D),
SH3i (E, F), β-Actin (G, H), and Connexin 43 (Cx43, I, J). The Z-discs in the MenaGT/GTVASP−/− appeared fractured (B, arrowheads) and clusters of
αII-Spectrin, SH3i, and β-Actin were found within the ruptured Z-discs and often associated with the emerging gaps (D, F, H; arrows). In contrast
to the convoluted organization of intercalated discs in wild-type hearts (I), intercalated discs in MenaGT/GTVASP−/− mice displayed a pronounced
step-like appearance with elongated and lateralized gap junctions (J, double arrow).
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/SH3i labeling, β-actin immunogold particles clustered in
the fractured Z-discs (Figure 12G and H).
Finally, we compared the morphology of intercalated
discs in wild-type and MenaGT/GTVASP−/− mice and
analyzed Connexin 43 localization. Whereas cardiac
muscle from wild-type mice displayed the typical con-
voluted organization of intercalated discs with compact
gap junctions intimately connected with adjacent des-
mosomes and adherens junctions, intercalated discs in
MenaGT/GTVASP−/− mice displayed a pronounced step-
like appearance with elongated, lateralized gap junc-
tions. Indeed, adherens junctions at both sides of the
elongated gap junctions were separated by almost the
entire length of a sarcomere (Figure 12I and J).
Thus, Mena/VASP double-deficiency results in struc-
tural alteration of Z- and intercalated discs. This may
explain the conduction delays and the development of
the dilated cardiomyopathy in MenaGT/GTVASP−/−
mice and supports the hypothesis of an important role
of β-cytoplasmic actin networks for the mechanical
support, myofibrillogenesis, and ion channel function
in the heart.
Discussion
In the present study, we analyzed the physiological
functions of Mena and VASP in the mammalian heart
and investigated the role of the proteins in the or-
ganization of cytoplasmic actin networks.
Stage-dependent expression of cytoskeletal proteins in
the mouse heart
We found that cardiac VASP expression was upregulated
in lysates from 1-week-old and adult hypertrophic
hearts, conditions in which the heart is confronted with
a sudden and dramatic increase in mechanical workload.
Mena expression followed a similar trend, but the pro-
tein is more robustly expressed in the adult heart,
pointing to a more specialized role of VASP in the devel-
oping or remodelling heart. The upregulation of the pro-
teins in the infant and hypertrophied heart could
partially be due to non-cardiomyocyte cells and fibrosis.
However, Mena and VASP protein levels were also
upregulated in cardiac myocytes isolated from mice
subjected to ascending aortic constriction [33] and from
the developing rat heart [7], demonstrating that the in-
creased protein expression is likely cardiomyocyte-
specific. Consistent with activation of β-adrenergic sig-
naling pathways, VASP from infant and hypertrophied
hearts was frequently PKA phosphorylated and displayed
its characteristic doublet on Western blots. How PKA-
mediated phosphorylation regulates VASP function under
these conditions is currently unknown and requires fur-
ther investigations.Taken together, Mena and VASP function may be es-
pecially important in heart development and remodeling.
However, additional studies on the role of the proteins
in embryonic and postnatal development and in hyper-
trophic conditions, including transverse aortic constric-
tion or sustained activation of β-adrenergic signaling, are
required to experimentally address this hypothesis.Cardiac phenotype of Mena/VASP single- and double-
deficient mice
The present study is the first to systematically address
the consequences of Mena-, VASP-, and Mena/VASP
double-deficiency in cardiac physiology.
Together with the histology data, our echocardiographic
and hemodynamic measurements revealed an important
role of Mena and VASP for the mechanical properties of
the heart. Left-ventricular performance was increasingly
impaired in adult VASP-, Mena-, and Mena/VASP double-
deficient mice and only the double-deficient animals devel-
oped dilated cardiomyopathy. Consistent with a higher ex-
pression level of Mena in the adult heart, this suggests that
Mena is more important for the mechanical properties of
the heart than VASP. Because conventional Mena−/− mice
display a cardiac phenotype, which is comparable to our
MenaGT/GT mice [34], the remaining Mena expression in
the brain of our MenaGT/GT mice does not seem to influ-
ence cardiac performance. With respect to cardiac me-
chanics, Mena and VASP can, to a certain extent,
compensate for the loss of the other family member. How-
ever, the functional compensation is not sufficient to pre-
serve full cardiac performance in the single gene-deficient
animals. We investigated Mena protein levels in VASP-
deficient animals and vice versa. However, consistent with
our previous findings [16], we could not detect a compen-
satory upregulation of the proteins (data not shown).
When we investigated the electrical conduction in
wild-type and mutant hearts, intra-atrial and intra-
ventricular propagation of electrical signals was equally
delayed in Mena/VASP single- and double-deficient
mice. In contrast to heart mechanics, this suggests that
Mena and VASP have indispensable functions in the
propagation of electrical signals, likely in the formation
of the gap junctions in intercalated discs.
Previously, a dominant negative strategy with cardiac-
specific overexpression of the VASP-EVH1 domain was
used to disrupt the in vivo function of Mena and VASP
[35]. Animals with high transgene expression developed
cardiac abnormalities and died within 2–6 weeks after
birth [35]. Because our Mena/VASP double-deficient
mice did not reveal an obviously reduced lifespan, it
is likely that the transgene caused off-target effects
and possibly affected other EVH1 domain-containing
proteins.
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complexes at Z- and intercalated discs
Our results revealed that Mena/VASP specifically inter-
act with a distinct αII-Spectrin splice variant (SH3i),
which is exclusively localized at Z- and intercalated discs
of cardiomyocytes. The SH3i isoform contains a 20
amino acid insertion C-terminal to the SH3 domain,
which enhances the binding to Mena and VASP in pull-
down assays. Similar to the isolated SH3 domain [10],
PKA-mediated VASP phosphorylation abrogates binding
of SH3i to VASP in vitro. However, it remains to be de-
tailed whether activation of β-adrenergic signaling path-
ways affects the Mena/VASP: SH3i complex formation
in vivo. Our immunoprecipitation experiments suggested
that Mena, SH3i, and actin assemble multi-protein com-
plexes at Z- and intercalated discs. Interestingly, we
could not detect other actin-binding proteins such as
CapZ in these complexes, arguing for the existence of
distinct actin networks in cardiomyocytes. We used
immunogold labeling to determine the distribution of
Mena in cardiac myocytes. At Z- and intercalated discs
of mouse cardiomyocytes, Mena localized to the edges
of the sarcomeres, where the thin filaments are an-
chored. Importantly, we could show for the first time
that actin filaments at these sites are, at least in part,
composed of the β-cytoplasmic actin isoform. In con-
trast, colocalization of Mena with the thin filaments of
the contractile machinery or the filamentous structures
projecting from the Z-disc termini towards the mito-
chondria was minor. This suggests that in the adult
mouse heart Mena is not involved in the regulation of
α-cardiac or γ-cytoplasmic actin fibers but specifically
interacts with β-cytoplasmic actin networks. However,
currently it is unknown how Mena and VASP may dis-
tinguish between different actin isoforms and two com-
monly held concepts may give an explanation. First,
Mena and VASP could discriminate between muscle and
cytoplasmic actin isoforms, which has been shown for a
subset of other actin-binding proteins including Thymo-
sin b4 and profilin [1]. All actin isoforms share at least
93% identity and β- and γ-actin differ by only four resi-
dues at the N-terminus. Up to now, the actin epitope,
which binds to Mena or VASP, has not been identified.
It is tempting to speculate that Mena and VASP may
favor binding to cytoplasmic actin isoforms. Indeed most
cellular effects of Mena and VASP, such as endothelial
barrier function, fibroblast migration, and axon guid-
ance, are associated with the regulation of β-actin actin
dynamics [10,11,36]. Moreover, profilin, which directly
interacts with Mena and VASP and increases the anti-
capping and filament elongation activities of the pro-
teins, binds cytoplasmic actin with higher affinity than
muscle actin [37]. Nevertheless, there may be a second
explanation for the isoform-specific interaction of theproteins with actin. Mena and VASP may be localized to
distinct subcellular regions, perhaps as a result of differ-
ential interactions with other proteins such as αII-
Spectrin. Because these interactions can be regulated by
cyclic nucleotide-dependent signaling pathways, this
may allow the cell to modulate actin dynamics in re-
sponse to external stimuli in a spatial and temporal de-
fined manner. In agreement with this concept, VASP
readily increases the filament assembly of muscle actin
in vitro [9,11], arguing against an isoform-selective actin
binding of VASP per se. To our knowledge, this is the
first study indicating that Mena and VASP interact with
actin fibers in an isoform-dependent manner.
Mena/VASP double-deficiency impairs Z- and intercalated
disc integrity
When we analyzed the morphology of cardiomyocytes in
our MenaGT/GTVASP−/− mice, Z-discs appeared wavy
and fractured. Furthermore αII-Spectrin, SH3i, and β-
actin formed clusters within the Z-discs and actin fila-
ments of the I-band appeared disorganized. It is tempt-
ing to speculate that Mena/VASP deficiency results in a
disruption of the multi-protein complexes with αII-
Spectrin and β-actin and thus impairs the structural in-
tegrity of the Z-discs, which in turn disrupts the anchor-
ing of the thin filaments from the I-band. However, we
cannot rule out that the ruptured Z-discs are the primary
consequence of Mena/VASP double-deficiency and that
clustering of αII-Spectrin and β-actin are secondary
effects. One finding that argues against a secondary effect
of αII-Spectrin and β-actin clustering, however, is the
sub-cellular distribution of α-Actinin in wild-type and
MenaGT/GTVASP−/− mice. Although the Z-disc structure
was clearly impaired in the MenaGT/GTVASP−/− mice, the
α-Actinin staining per se was indistinguishable from wild-
type mice, indicating that in contrast to αII-Spectrin and
β-actin other components of the actin network at Z-discs
are not affected by the malformation of the Z-discs.
Mena/VASP double-deficiency also impaired the structural
integrity of intercalated discs. In our MenaGT/GTVASP−/−
mice, especially the morphology of gap junctions was
markedly changed. In the double-deficient animals,
Connexin 43-positive gap junctions were excessively
lateralized and elongated and clearly separated from
desmosomes and adherens junctions. Currently, in-
formation how actin networks affect gap junction for-
mation is sparse. Interactions of connexins with the
actin cytoskeleton and associated proteins appear to
stabilize gap junctions at the plasma membrane and
αII-Spectrin has been shown to co-precipitate with
Cx43, likely via interaction with ZO-1 [38]. Our data
indicate that especially SH3i may be involved in cytoskeletal
organization at gap junctions as SH3i precipitated signifi-
cantly more Cx43 and Mena than the general αII-Spectrin
Figure 13 Proposed role of Mena/VASP and αII-Spectrin for cytoplasmic actin assembly in the mammalian heart. (A) Diagram of
myofibrils and junctions in two adjacent cardiomyocytes. The longitudinal force generated by sliding of actin and myosin fibers along each other
is transduced between adjacent sarcomeres at the Z-disc and between adjacent cardiomyocytes at the adherens junctions of the intercalated
disc. In contrast to the transverse adherens junctions, which are located at the end of myofibrils, gap junctions are often found in close
association with mitochondria and and propagate electrical signals between cells by exchange of calcium and sodium ions. Whereas actin fibers
of the contractile machinery are mainly composed of α-cardiac actin (red), actin filaments at gap junctions and the edges of Z- and intercalated
discs, where the thin filaments are anchored, are composed of β-cytoplasmic actin (blue). (B-D) Proposed mechanism how Mena/VASP and
αII-Spectrin are thought to regulate cytoplasmic actin networks at Z-discs (B), intercalated discs (C), and gap junctions (D). For simplicity reasons,
only Mena is depicted. Complexes of Mena/VASP and SH3i regulate β-actin networks by association at or near the barbed ends of β-actin
filaments. Possibly, these complexes protect the barbed ends of thin filaments from capping by CapZ or modulate the geometry of the actin
network by the intrinsic actin polymerization/bundling activity of Mena and VASP. Notably, heterotetrameric Spectrins, which are composed of
two α- and two β-subunits, also regulate actin networks and are well known F-actin crosslinking proteins. Therefore disrupted Mena/VASP:SH3i
complex formation in MenaGT/GTVASP−/− mice may explain the disturbed morphology of Z- and intercalated discs, and the development of
dilated cardiomyopathy and conduction abnormalities.
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Mena (and VASP) may regulate cytoplasmic networks and
thereby stabilize the assembly and intercellular communica-
tion of gap junctions. In agreement with this hypothesis,
blocking of actin dynamics by cytochalasin B treatment orblocking the association of Cx43 with the actin cytoskeleton
led to a significant increase in the gap junction size [39,40].
Nevertheless, it remains unclear, why the enlarged gap junc-
tions in our MenaGT/GTVASP−/− mice result in an impaired
electrical conduction and prolonged PQ and QRS complexes
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the gap junctions or a defective formation of gap junction
channels between opposing cells. However, further experi-
ments are required to address this question.
Conclusions
We propose a model how Mena/VASP and αII-
Spectrin regulate β-cytoplasmic actin networks at
Z- and intercalated discs of the mammalian heart
(Figure 13). Complexes of Mena/VASP and SH3i regu-
late β-actin networks by association at or near the
barbed ends of β-actin filaments. Possibly, these com-
plexes protect the barbed ends of thin filaments from
capping or modulate the geometry of the actin network
with implications for mechanical support, myofibriloge-
nesis, and ion channel function. Conversely, disrupted
Mena/SH3i complex formation in MenaGT/GTVASP−/−
mice impairs the integrity of Z- and intercalated discs and
results in dilated cardiomyopathy and conduction
abnormalities.Methods
Generation of MenaGT/GT and MenaGT/GTVASP−/− mice
The mouse Mena gene is located on chromosome 1
spanning about 115 kb of genomic sequence (BLAST-
like alignment tool, BLAT [41], Assembly NCBI37/mm9).
To disrupt the Mena gene in mice, we generated a mouse
strain, using the RRG138 embryonic stem (ES) cell
line from BayGenomics (http://www.genetrap.org). In
RRG138, the gene trap vector pGT0Lxf is inserted be-
tween exons 2 and 3 of the mouse Mena gene (Figure 2)
and single insertion of the vector was confirmed by South-
ern blot analysis. 129/Ola ES cells heterozygous for the
targeted mutation were microinjected into C57Bl/6 blasto-
cysts and implanted into pseudopregnant foster mothers.
Male chimeras were mated with C57Bl/6 females to obtain
heterozygous Mena+/GT mice. Offspring were genotyped
using a forward primer located in exon 2 of the mouse
Mena gene (me_F3: 5′ – TGGGCAGAAAGATTCAA
GACC – 3′) either in combination with a reverse pri-
mer in Mena intron 2 (me_in2_R2: 5′ – CCAGTTTCA
ATGCCCATTCCTT – 3′) to amplify the 1123 bp
wild-type fragment or in combination with a reverse
primer in the gene trap vector (pGT0Lxf_R2: 5′ – CG
GATCTCAAACTCTCCTCC – 3′) to amplify the 824
bp knockout fragment. TA-cloning and sequencing of
the knockout PCR product confirmed targeting of the
mouse Mena gene and allowed to map the insertion of the
gene trap vector 682 bp downstream of Mena exon 2.
VASP-deficient mice have been described previously [16]
and were mated to MenaGT/GT mice to generate Mena/
VASP double-deficient animals (MenaGT/GTVASP−/−). In the
present study, 8–12 months old VASP-, Mena-, and Mena/VASP double-deficient mice and controls of a mixed 129/
Ola X C57Bl/6 background were used for all experiments.
Animal experiments
All animal experiments were performed according to
the relevant regulatory standards and were approved
by the local government (license to KS and PMB,
#621-2531.01-25/05, #55.2-2531.01-62/08, and #55.2-
2531.01-95/11).
Transverse aortic constriction (TAC)
Male mice were anesthetized using isoflurane and the
transversal aorta was prepared after jugular incision. A
27-gauge needle was tied against the aorta using a 5–0
non-absorbable suture. After removal of the 27-gauge
needle, skin was closed, and the mice were kept on a
warming plate until recovery from anesthesia. After 3
weeks of TAC, mice were then sacrificed under anaes-
thesia, the hearts were weighed and the left ventricles
were dissected for protein extraction.
Echocardiography
Serial transthoracic echocardiography (Aplio, Toshiba,
Netherlands) was performed under light isoflurane
anaesthesia and spontaneous respiration by a single
researcher experienced in rodent echocardiography blin-
ded to mouse genotype. From two-dimensional short
axis imaging, endocardial borders were traced at end-
systole and end-diastole utilizing a prototype off-line
analysis system (NICE, Toshiba Medical Systems, The
Netherlands). Measurements were performed at the
mid-papillary muscle level. The end-systolic (smallest)
and enddiastolic (largest) cavity areas were determined.
Using the end-systolic (ESA) and-diastolic areas (EDA),
fractional area changes were calculated ((EDA-ESA)/
EDA). Only animals with a heart rate greater than 450/
min were included.
Invasive hemodynamics
Terminal measurements of left ventricular pressure
(LVP) were performed in 1% isoflurane anesthetized
mice with a 1.4F micromanometer-tipped catheter and
MPVS Ultra amplifier (Millar Instruments). After 30
min of stabilization, 30 sec of data were collected and
analyzed with Chart 7.3 from ADInstruments running
on PowerLab 16/30, including heart rate, systolic and
diastolic LVP, and the first derivatives of LVP, ±dP/dt.
Only animals with a heart rate greater than 450/min
were included.
High resolution ECG recordings
Mice were anesthetized using isoflurane (0.8%) and
kept on a warming plate (37°C) throughout the experi-
ment. Lead I ECG recordings were captured at a
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PowerLab 8/35 with BIO amplifier) and original ECG
recordings were analyzed with the ecg-auto software
(version 2.5.0.3, emka technologies).Antibodies and fluorescent phalloidin
Polyclonal rabbit anti-Mena antibodies were raised against a
purified glutathione-S-transferase (GST, GE-Healthcare)
fusion protein comprising mouse Mena amino acids
L147-L279 (numbering according to NCBI protein ID
AAC52863). Antibodies were immunoselected with a puri-
fied maltose-binding fusion protein (MBP, New England
Biolabs) comprising the same mouse Mena residues. For
double-immunofluorescence studies, we conjugated the puri-
fied Mena antibodies with fluorescein isothiocyanate (FITC,
Sigma). Rabbit antibodies against the general αII-Spectrin
protein isoform were generated and immunoselected with a
purified GST fusion protein comprising amino acids E970-
D1025 of the human αII-Spectrin sequence (protein ID
AAH53521). To remove αI-Spectrin- and GST-specific anti-
bodies, the purified antiserum was immunodepleted with an
excess of a GST fusion protein comprising αI-Spectrin resi-
dues A978-A1033 (protein ID NP_035595). Other antibodies
used were anti-VASP (IG-731, Immunoglobe), anti-SH3i
[30], anti-GST [10], anti-glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH, mAB 374, Chemicon), anti-β-Tubu-
lin (T8328, Sigma), anti-β-cytoplasmic actin (13E5, Cell
Signalling; A1978, Sigma), anti-γ-cytoplasmic actin
(A8481, Sigma), anti-CapZ (AB6017, Millipore), anti-Cx43
(sc-6560, Santa Cruz; 710700, Invitrogen), anti-α-Actinin
(A7811, Sigma). Horseradish peroxidase-conjugated sec-
ondary antibodies were from Dianova or eBioscience,
fluorescence-conjugated antibodies (Alexa-fluor 488, 594,
or 647) from Molecular Probes. Fluorescent phalloidin
(P1951, Sigma; A22287, Invitrogen) was used to visualize
F-actin.Organ lysates and Western blotting
For Western blotting, 100 mg mouse organ was homoge-
nized in 2 ml lysis buffer (2% SDS, 1x PBS, 2x complete
EDTA-free protease inhibitors (Roche)) using an Ultra
Turrax. Following centrifugation for 30 min at 20,000 x g,
protein content of the supernatant was determined by UV
spectroscopy and 30 μg total protein was resolved by poly-
acrylamide gel electrophoresis and transferred to nitrocel-
lulose sheets. Membranes were blocked in 5% skimmed
milk in PBS, incubated with primary and horseradish
peroxidase-conjugated secondary antibodies in blocking
solution, and detection was performed with a chemilumin-
escence substrate (ECL Plus, GE-Healthcare). Equal pro-
tein loading was confirmed with β-Tubulin- or GAPDH-
specific antibodies.Histological analyses
For histological analysis, hearts were fixed in a neutral
buffered methanol-free formalin solution for 24 h and
then embedded in paraffin. 5 μm transverse sections
from the middle of wild-type and Mena/VASP double-
deficient hearts were stained with hematoxilin/eosin
or 0.1% picrosirius red according to standard protocols.
Representative photographs of the transilluminated
stained sections on a Zeiss stage micrometer were col-
lected with a Canon EOS 1000D digital camera.
For the analysis of cross sectional cell sizes, standard
HE-stained heart sections were mounted with VectaShield
mounting medium (Vector Laboratories), images were
taken with a Keyence BZ digital microscope (Keyence,
Germany), and cross-sectional areas of myocytes dis-
playing round-shaped nuclei were quantified using the
ImageJ software (NIH).
RNA preparation and quantitative real-time PCR analysis
RNA was extracted from frozen LV samples of 6 male
mice per group using a Qiagen tissue RNA kit. cDNA
was synthesized from 100 ng of total RNA with Super-
script (Invitrogen). Quantitative real-time PCR was
performed (iCycler, Biorad) with commercially avai-
lable TaqMan probes for ANP, β-MHC, SMA, Col I,
Col III, and GAPDH (Invitrogen). Target gene mRNA
levels in MenaGT/GTVASP−/− mice were normalized to
GAPDH expressed relative to wild-type mice using the
2^(-ΔΔCT) method.
Isolation of cardiomyocytes
Mice were anesthetized in a gas chamber with iso-
flurane, hearts were excised and mounted on a Langen
dorff perfusion-system and were perfused with a nomin-
ally calcium-free Tyrodes’ solution containing (in mM)
NaCl 113, KCl 4.7, KH2PO4 0.6, Na2HPO4x2H2O 0.6,
MgSO4x7H2O 1.2, NaHCO3 12, KHCO3 10, HEPES 10,
Taurine 30, BDM 10, glucose 5.5, phenol-red 0.032 for 4
min at 37°C and pH 7.4. Then, perfusion solution was
switched to the same solution containing 7.5 mg/ml
liberase 1 (Roche diagnostics, Mannheim, Germany),
trypsin 0.6% and 0.125 mM CaCl2. Perfusion was contin-
ued for about 3 min until the heart became flaccid. Ven-
tricular tissue was removed, cut into small pieces and
dispersed until no solid cardiac tissue was left. Shortly
after, cells were on plated Laminin-coated chamber
slides (Nunc) and then prepared for immunofluores-
cence microscopy.
GST pull-down and immunoprecipitation experiments
cDNA parts of the general mouse αII-Spectrin (protein
ID CAM46235) or SH3i (AAI50942) isoform were
subcloned into pGEX-6P2 vector (GE Healthcare) to
generate constructs termed “A”, “SH3”, “α9”, and “α9A”
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spliced 20 amino acids TRITKEAGSVSLRMKQVEEL,
which are only present in SH3i, the two protein isoforms
are identical. A and α9A are specific for SH3i and en-
code amino acids T1053-L1072 and Q893-E1088, re-
spectively. The W1004R mutant was obtained from α9A
by replacing Trp1004 with an arginine residue by site-
directed mutagenesis. α9 is specific for the general αII-
Spectrin isoform and encodes amino acids Q893-E1068.
GST+SH3 encodes the SH3 domain, which is present in
both isoforms (E970-D1025). GST and the four GST-
fusion proteins were expressed in E.coli and affinity
purified on glutathione sepharose beads (compare
Figure 10C). For GST pull-down assays, hearts of wild-
type mice (100 mg) were homogenized in ice-cold 40
mM Hepes-NaOH, pH 7.4, 75 mM NaCl, 1% NP40, and
protease inhibitors (Roche) using a Polytron PT3100 ho-
mogenizer equipped with a PT-DA 3007 dispersing ag-
gregate. Lysates were cleared by centrifugation (17,000 x
g, 4°C, 15 min) and incubated with 5 μg immobilized
GST or equimolar amounts of the GST-fusion proteins.
Precipitated material was analyzed with anti-Mena and
anti-VASP antibodies. GST pull-down assays with puri-
fied recombinant VASP were performed essentially as
described [10].
For immunoprecipitation experiments, heart lysates
were prepared as described above and then incubated
with 5 μg purified anti-Mena, anti-αII-Spectrin, or anti-
SH3i antibodies, followed by protein A-sepharose (GE
Healthcare). Purified GST-specific antibodies served as
control. After extensive washing in lysis buffer, precipi-
tates were resuspended in SDS sample buffer, resolved
by SDS-PAGE, and analyzed by Western blotting em-
ploying standard methods. To quantify the amount of
Mena and Cx43, which is co-precipitated with the gen-
eral αII-Spectrin or the SH3i variant, respectively, we
performed densitometric scans (ImageJ version 1.45s,
National Institute of Health, USA). For each IP/Western
blot, the signal ratio of precipitated protein vs. a con-
stant amount of heart lysate was calculated. For Mena
and Cx43, ratios of SH3i precipitations are given relative
to the ratios of αII-Spectrin precipitations.
Immunohistochemistry
All incubation and washing steps were performed at room
temperature in a buffer containing 10 mM PIPES pH6.8,
150 mM NaCl, 5 mM EGTA, 5 mM glucose, 5 mMMgCl2.
7 μm mouse heart cryosections or isolated mouse
cardiomyocytes were fixed in 4% paraformaldehyde, exten-
sively washed with 50 mM ammonium chloride, perme-
abilized with 0.1% Triton, blocked in 10% goat serum for 1
h, and overnight incubated with primary antibodies in 10%
goat serum. Following extensive washing, samples were in-
cubated with the fluorescence-conjugated secondaryantibodies and fluorescence-conjugated phalloidin for 1.5
h. After additional three rounds of washing, samples were
incubated with FITC-conjugated Mena antibodies, washed
again, and mounted with Mowiol (Hoechst). Stained sec-
tions were investigated using a Leica SP5 confocal micro-
scope equipped with a 100-fold oil immersion objective.
Images were acquired and prepared for presentation using
the LAS AF 2.6.0 software from Leica. Pearson’s correl-
ation and Mander’s overlap coefficients were calculated
using the Intensity Correlation Analysis Plugin available
for ImageJ.
Pre-embedding Immuno-electron microscopy
Mouse cardiac tissue used for this study was fixed in 4%
paraformaldehyde, 15% saturated picric acid in 0.1 M
phosphate buffer, pH 7.4, overnight at 4°C. Longitudinal
sections were cut on a vibratome (Leica VT 1000S) at a
thickness of 50 μm, blocked in 20% NGS in PBS and
were incubated with primary antibodies in phosphate-
buffered saline containing 5% normal goat serum
(Vector Laboratories, Burlingame, CA, USA) overnight
at 4°C. After washes in PBS, the sections were incubated
with 1.4 nm gold-coupled secondary antibodies in PBS
(Nanoprobes, Stony Brook, NY, USA) overnight at 4°C.
After several washes the sections were postfixed in 1%
glutaraldehyde in PBS for 10 min and then reacted with
HQ Silver kit (Nanoprobes). After treatment with OsO4,
sections were stained with uranyl acetate, dehydrated,
and embedded in Durcupan resin (Fluka, Switzerland).
Ultrathin sections were prepared (Ultracut S; Leica,
Germany) and examined with a ZEISS 910 electron
microscope.
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